# COVID-19: SARS-CoV-2-CZ-PREVAL-II Study

> **NCT05096962** · — · COMPLETED · sponsor: **Institute of Health Information and Statistics of the Czech Republic** · enrollment: 7268 (actual)

## Conditions studied

- COVID-19
- SARS-CoV-2 Infection

## Interventions

- **DIAGNOSTIC_TEST:** Quantitative analysis of SARS-CoV-2 antibodies
- **DIAGNOSTIC_TEST:** Cellular immunity

## Key facts

- **NCT ID:** NCT05096962
- **Lead sponsor:** Institute of Health Information and Statistics of the Czech Republic
- **Sponsor class:** OTHER_GOV
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-09-13
- **Primary completion:** 2021-10-31
- **Final completion:** 2022-02-24
- **Target enrollment:** 7268 (ACTUAL)
- **Last updated:** 2022-11-28

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05096962

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05096962, "COVID-19: SARS-CoV-2-CZ-PREVAL-II Study". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT05096962. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*